SEC Form 4 · accession 0001140361-15-043626
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 9:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Dec 1, 2015 | S | 500 | $59.87 | D | 76,111 | I | Douglas Family Trust |
| ResMed Common Stock | Dec 1, 2015 | M | 5,833 | $19.25 | A | 81,944 | I | Douglas Family Trust |
| ResMed Common StockF3 | Dec 1, 2015 | S | 5,833 | $59.76 | D | 76,111 | I | Douglas Family Trust |
| ResMed Common Stock | holding | — | — | — | 31,304 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $19.25 | Dec 1, 2015 | M | 5,833 | D | Feb 3, 2007 | Feb 3, 2016 | ResMed Common Stock | 5,833 | 5,837 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable.
- F3This transaction was executed in multiple trades at prices ranging from $59.75 to $59.80. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.